Head to Head Analysis Vaccinex Alnylam Pharmaceuticals - Defense World
Slightly above 67% of Vaccinex's investor base is looking to short. The analysis of overall sentiment of trading Vaccinex stock suggests that many investors are alarmed at this time. Vaccinex's investing sentiment can be driven by a variety of factors including economic data, Vaccinex's earnings reports, geopolitical events, and overall market trends.
Vaccinex |
Head to Head Analysis Vaccinex Alnylam Pharmaceuticals Defense World
Read at news.google.com
 |
Vaccinex Fundamental Analysis
We analyze Vaccinex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaccinex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaccinex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Vaccinex is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Vaccinex Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaccinex stock to make a market-neutral strategy. Peer analysis of Vaccinex could also be used in its relative valuation, which is a method of valuing Vaccinex by comparing valuation metrics with similar companies.
Peers
Vaccinex Related Equities
| SLRX | Salarius Pharmaceuticals | 29.46 | ||||
| SRZN | Surrozen | 7.48 | ||||
| RNXT | RenovoRx | 4.12 | ||||
| ELDN | Eledon Pharmaceuticals | 2.90 | ||||
| GOVX | GeoVax Labs | 0.68 | ||||
| MNPR | Monopar Therapeutics | 0.58 | ||||
| SABS | SAB Biotherapeutics | 0.57 | ||||
| TARA | Protara Therapeutics | 0.57 | ||||
| FBRX | Forte Biosciences | 0.64 | ||||
| ERAS | Erasca | 0.71 | ||||
| ANEB | Anebulo Pharmaceuticals | 1.60 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |